BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 22550000)

  • 1. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
    Dieudonné FX; Marion A; Marie PJ; Modrowski D
    J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells.
    Dieudonné FX; Marion A; Haÿ E; Marie PJ; Modrowski D
    Cancer Res; 2010 Jul; 70(13):5399-408. PubMed ID: 20530678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma.
    Marion A; Dieudonné FX; Patiño-Garcia A; Lecanda F; Marie PJ; Modrowski D
    Int J Cancer; 2012 Jun; 130(11):2514-25. PubMed ID: 21681744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation.
    Zhou Y; Liang C; Xue F; Chen W; Zhi X; Feng X; Bai X; Liang T
    Oncotarget; 2015 Apr; 6(12):10350-65. PubMed ID: 25871400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
    Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
    Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
    Wu BQ; Cao Y; Bi ZG
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
    Parr C; Mirzaei N; Christian M; Sastre M
    FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
    Wang DZ; Gao JF; Jing SF; Wei H; Huang XY; Li CD
    Drug Res (Stuttg); 2015 Nov; 65(11):597-601. PubMed ID: 25514117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
    Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
    Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
    Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
    Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
    Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of TCF/β-Catenin Binding Impairs Wnt Signaling and Induces Apoptosis in Soft Tissue Sarcoma Cells.
    Martinez-Font E; Felipe-Abrio I; Calabuig-Fariñas S; Ramos R; Terrasa J; Vögler O; Alemany R; Martín-Broto J; Obrador-Hevia A
    Mol Cancer Ther; 2017 Jun; 16(6):1166-1176. PubMed ID: 28292937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.